{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:28Z","timestamp":1792782928322,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Special Scientific Research Fund of Public Welfare Profession of National Health and Family Planning Commission","award":["201502026"],"award-info":[{"award-number":["201502026"]}],"id":[{"id":"https:\/\/ror.org\/052eegr76","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Jiangsu Province Creation Team and Leading Talents project","award":["Zhang F"],"award-info":[{"award-number":["Zhang F"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670495"],"award-info":[{"award-number":["81670495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600417"],"award-info":[{"award-number":["81600417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Clinical Research Center for Digestive Diseases","award":["2015BAI13B07"],"award-info":[{"award-number":["2015BAI13B07"]}],"id":[{"id":"https:\/\/ror.org\/00a2x9d51","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Jiangsu Province Society Development project","award":["BE2018751"],"award-info":[{"award-number":["BE2018751"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00253-018-9447-x","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T11:14:17Z","timestamp":1540379657000},"page":"349-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn\u2019s disease"],"prefix":"10.1007","volume":"103","author":[{"given":"Pan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bota","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-1144","authenticated-orcid":false,"given":"Faming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"key":"9447_CR1","doi-asserted-by":"publisher","unstructured":"Bazanella M, Maier TV, Clavel T, Lagkouvardos I, Lucio M, Maldonado-Gomez MX, Autran C, Walter J, Bode L, Schmitt-Kopplin P, Haller D (2017) Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome. Am J Clin Nutr ajcn157529. doi:\n                    https:\/\/doi.org\/10.3945\/ajcn.117.157529","DOI":"10.3945\/ajcn.117.157529"},{"issue":"11","key":"9447_CR2","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2(11):2692\u20132703. \n                    https:\/\/doi.org\/10.1038\/nprot.2007.376","journal-title":"Nat Protoc"},{"issue":"12","key":"9447_CR3","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.crohns.2014.08.006","volume":"8","author":"RJ Colman","year":"2014","unstructured":"Colman RJ, Rubin DT (2014) Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 8(12):1569\u20131581. \n                    https:\/\/doi.org\/10.1016\/j.crohns.2014.08.006","journal-title":"J Crohns Colitis"},{"issue":"1","key":"9447_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/jgh.12727","volume":"30","author":"B Cui","year":"2015","unstructured":"Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F (2015a) Fecal microbiota transplantation through mid-gut for refractory Crohn\u2019s disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 30(1):51\u201358. \n                    https:\/\/doi.org\/10.1111\/jgh.12727","journal-title":"J Gastroenterol Hepatol"},{"key":"9447_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12967-015-0646-2","volume":"13","author":"B Cui","year":"2015","unstructured":"Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, Xu H, Xiang J, He Z, Zhang T, Nie Y, Wu K, Fan D, Ji G, Zhang F (2015b) Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med 13:298. \n                    https:\/\/doi.org\/10.1186\/s12967-015-0646-2","journal-title":"J Transl Med"},{"issue":"1","key":"9447_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3748\/wjg.v20.i1.163","volume":"20","author":"T Dawiskiba","year":"2014","unstructured":"Dawiskiba T, Deja S, Mulak A, Zabek A, Jawien E, Pawelka D, Banasik M, Mastalerz-Migas A, Balcerzak W, Kaliszewski K, Skora J, Barc P, Korta K, Pormanczuk K, Szyber P, Litarski A, Mlynarz P (2014) Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J Gastroenterol 20(1):163\u2013174. \n                    https:\/\/doi.org\/10.3748\/wjg.v20.i1.163","journal-title":"World J Gastroenterol"},{"issue":"4","key":"9447_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/jgh.12073","volume":"28","author":"T Fujimoto","year":"2013","unstructured":"Fujimoto T, Imaeda H, Takahashi K, Kasumi E, Bamba S, Fujiyama Y, Andoh A (2013) Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn\u2019s disease. J Gastroenterol Hepatol 28(4):613\u2013619. \n                    https:\/\/doi.org\/10.1111\/jgh.12073","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"9447_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, Gonzalez A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ (2014) The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe 15(3):382\u2013392. \n                    https:\/\/doi.org\/10.1016\/j.chom.2014.02.005","journal-title":"Cell Host Microbe"},{"issue":"2","key":"9447_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/ibd\/izx035","volume":"24","author":"A Goyal","year":"2018","unstructured":"Goyal A, Yeh A, Bush BR, Firek BA, Siebold LM, Rogers MB, Kufen AD, Morowitz MJ (2018) Safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease. Inflamm Bowel Dis 24(2):410\u2013421. \n                    https:\/\/doi.org\/10.1093\/ibd\/izx035","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"9447_CR10","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1038\/s41598-017-04984-z","volume":"7","author":"Z He","year":"2017","unstructured":"He Z, Li P, Zhu J, Cui B, Xu L, Xiang J, Zhang T, Long C, Huang G, Ji G, Nie Y, Wu K, Fan D, Zhang F (2017) Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn\u2019s disease complicated with inflammatory mass. Sci Rep 7(1):4753. \n                    https:\/\/doi.org\/10.1038\/s41598-017-04984-z","journal-title":"Sci Rep"},{"issue":"6","key":"9447_CR11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ajg.2015.149","volume":"110","author":"KL Kolho","year":"2015","unstructured":"Kolho KL, Korpela K, Jaakkola T, Pichai MV, Zoetendal EG, Salonen A, de Vos WM (2015) Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation. Am J Gastroenterol 110(6):921\u2013930. \n                    https:\/\/doi.org\/10.1038\/ajg.2015.149","journal-title":"Am J Gastroenterol"},{"key":"9447_CR12","doi-asserted-by":"publisher","first-page":"12955","DOI":"10.1038\/srep12955","volume":"5","author":"J Landy","year":"2015","unstructured":"Landy J, Walker AW, Li JV, Al-Hassi HO, Ronde E, English NR, Mann ER, Bernardo D, McLaughlin SD, Parkhill J, Ciclitira PJ, Clark SK, Knight SC, Hart AL (2015) Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci Rep 5:12955. \n                    https:\/\/doi.org\/10.1038\/srep12955","journal-title":"Sci Rep"},{"issue":"1","key":"9447_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12876-018-0766-2","volume":"18","author":"C Long","year":"2018","unstructured":"Long C, Yu Y, Cui B, Jagessar SAR, Zhang J, Ji G, Huang G, Zhang F (2018) A novel quick transendoscopic enteral tubing in mid-gut: technique and training with video. BMC Gastroenterol 18(1):37. \n                    https:\/\/doi.org\/10.1186\/s12876-018-0766-2","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"9447_CR14","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ijo.2015.40","volume":"39","author":"A Miccheli","year":"2015","unstructured":"Miccheli A, Capuani G, Marini F, Tomassini A, Pratico G, Ceccarelli S, Gnani D, Baviera G, Alisi A, Putignani L, Nobili V (2015) Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. Int J Obes 39(7):1118\u20131125. \n                    https:\/\/doi.org\/10.1038\/ijo.2015.40","journal-title":"Int J Obes"},{"issue":"1","key":"9447_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, Lee CH (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149(1):102\u2013109 e6. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2015.04.001","journal-title":"Gastroenterology"},{"issue":"10","key":"9447_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT (2017) Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 14(10):573\u2013584. \n                    https:\/\/doi.org\/10.1038\/nrgastro.2017.88","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6086","key":"9447_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S (2012) Host-gut microbiota metabolic interactions. Science 336(6086):1262\u20131267. \n                    https:\/\/doi.org\/10.1126\/science.1223813","journal-title":"Science"},{"issue":"5","key":"9447_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","volume":"66","author":"V Pascal","year":"2017","unstructured":"Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C (2017) A microbial signature for Crohn\u2019s disease. Gut 66(5):813\u2013822. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2016-313235","journal-title":"Gut"},{"key":"9447_CR19","doi-asserted-by":"crossref","unstructured":"Simone SL, Ana Z, Vladimir B, Costea PI, Rajna H, Falk H, Huerta-Cepas J, Nieuwdorp M, Saloj\u00e4rvi J, Voigt AY, Zeller G, Sunagawa S, de Vos WM, Bork P (2016) Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352(6285)","DOI":"10.1126\/science.aad8852"},{"issue":"43","key":"9447_CR20","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottiere HM, Dore J, Marteau P, Seksik P, Langella P (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105(43):16731\u201316736. \n                    https:\/\/doi.org\/10.1073\/pnas.0804812105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9447_CR21","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/j.crohns.2012.04.019","volume":"7","author":"NS Stephens","year":"2013","unstructured":"Stephens NS, Siffledeen J, Su X, Murdoch TB, Fedorak RN, Slupsky CM (2013) Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy. J Crohns Colitis 7(2):e42\u2013e48. \n                    https:\/\/doi.org\/10.1016\/j.crohns.2012.04.019","journal-title":"J Crohns Colitis"},{"issue":"4","key":"9447_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MOG.0b013e328361f488","volume":"29","author":"M Storr","year":"2013","unstructured":"Storr M, Vogel HJ, Schicho R (2013) Metabolomics: is it useful for inflammatory bowel diseases? Curr Opin Gastroenterol 29(4):378\u2013383. \n                    https:\/\/doi.org\/10.1097\/MOG.0b013e328361f488","journal-title":"Curr Opin Gastroenterol"},{"issue":"9","key":"9447_CR23","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/ibd.21606","volume":"17","author":"J Strauss","year":"2011","unstructured":"Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, Lynch T, Allen-Vercoe E (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971\u20131978. \n                    https:\/\/doi.org\/10.1002\/ibd.21606","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"9447_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/MIB.0000000000000307","volume":"21","author":"DL Suskind","year":"2015","unstructured":"Suskind DL, Brittnacher MJ, Wahbeh G, Shaffer ML, Hayden HS, Qin X, Singh N, Damman CJ, Hager KR, Nielson H, Miller SI (2015) Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn\u2019s disease. Inflamm Bowel Dis 21(3):556\u2013563. \n                    https:\/\/doi.org\/10.1097\/MIB.0000000000000307","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"9447_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176\u2013181. \n                    https:\/\/doi.org\/10.1016\/S1053-4296(03)00031-6","journal-title":"Semin Radiat Oncol"},{"issue":"1\u20132","key":"9447_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jchromb.2006.09.015","volume":"851","author":"D Tsikas","year":"2007","unstructured":"Tsikas D, Thum T, Becker T, Pham VV, Chobanyan K, Mitschke A, Beckmann B, Gutzki FM, Bauersachs J, Stichtenoth DO (2007) Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease. J Chromatogr B Anal Technol Biomed Life Sci 851(1\u20132):229\u2013239. \n                    https:\/\/doi.org\/10.1016\/j.jchromb.2006.09.015","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"9","key":"9447_CR27","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1097\/MIB.0000000000000893","volume":"22","author":"BP Vaughn","year":"2016","unstructured":"Vaughn BP, Vatanen T, Allegretti JR, Bai A, Xavier RJ, Korzenik J, Gevers D, Ting A, Robson SC, Moss AC (2016) Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn\u2019s disease. Inflamm Bowel Dis 22(9):2182\u20132190. \n                    https:\/\/doi.org\/10.1097\/MIB.0000000000000893","journal-title":"Inflamm Bowel Dis"},{"issue":"14","key":"9447_CR28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1182\/blood-2015-04-638858","volume":"126","author":"D Weber","year":"2015","unstructured":"Weber D, Oefner PJ, Hiergeist A, Koestler J, Gessner A, Weber M, Hahn J, Wolff D, Stammler F, Spang R, Herr W, Dettmer K, Holler E (2015) Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood 126(14):1723\u20131728. \n                    https:\/\/doi.org\/10.1182\/blood-2015-04-638858","journal-title":"Blood"},{"issue":"13","key":"9447_CR29","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1021\/ac060209g","volume":"78","author":"AM Weljie","year":"2006","unstructured":"Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM (2006) Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78(13):4430\u20134442","journal-title":"Anal Chem"},{"key":"9447_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-230X-10-108","volume":"10","author":"HR Williams","year":"2010","unstructured":"Williams HR, Cox IJ, Walker DG, Cobbold JF, Taylor-Robinson SD, Marshall SE, Orchard TR (2010) Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn\u2019s disease. BMC Gastroenterol 10:108. \n                    https:\/\/doi.org\/10.1186\/1471-230X-10-108","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"9447_CR31","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1007\/s10620-015-3797-3","volume":"60","author":"A Wilson","year":"2015","unstructured":"Wilson A, Teft WA, Morse BL, Choi YH, Woolsey S, DeGorter MK, Hegele RA, Tirona RG, Kim RB (2015) Trimethylamine-N-oxide: a novel biomarker for the identification of inflammatory bowel disease. Dig Dis Sci 60(12):3620\u20133630. \n                    https:\/\/doi.org\/10.1007\/s10620-015-3797-3","journal-title":"Dig Dis Sci"},{"issue":"30","key":"9447_CR32","doi-asserted-by":"publisher","first-page":"e4055","DOI":"10.1097\/MD.0000000000004055","volume":"95","author":"L Xu","year":"2016","unstructured":"Xu L, Zhang T, Cui B, He Z, Xiang J, Long C, Peng Z, Li P, Huang G, Ji G, Zhang F (2016) Clinical efficacy maintains patients\u2019 positive attitudes toward fecal microbiota transplantation. Medicine (Baltimore) 95(30):e4055. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000004055","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"9447_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","volume":"9","author":"F Zhang","year":"2018","unstructured":"Zhang F, Cui B, He X, Nie Y, Wu K, Fan D, Group FM-sS (2018) Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell 9(5):462\u2013473. \n                    https:\/\/doi.org\/10.1007\/s13238-018-0541-8","journal-title":"Protein Cell"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-018-9447-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-018-9447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-018-9447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T19:57:18Z","timestamp":1571860638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-018-9447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["9447"],"URL":"https:\/\/doi.org\/10.1007\/s00253-018-9447-x","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,24]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Faming Zhang is the core inventor of GenFMTer and TET, and the founder of nonprofit China fmtBank.\u00a0Other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Second Affiliated Hospital of Nanjing Medical University Institutional Review Board. All eligible subjects provided written informed consents prior to participation in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}